Anne Jarry

6PUBLICATIONS
49CO-AUTHORS
AllergyCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 03, 2026
Unveiling the immune microenvironment in sinonasal intestinal type adenocarcinoma: new arguments for immunotherapy.

|Jul 03, 2026
Intratumoral enrichment and suppressive activity of DP8α regulatory T cells in human colorectal cancer.

|Jun 08, 2023
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers.

Marine Fidelle, Conrad Rauber, Carolina Alves Costa Silva

|Sep 09, 2022
Defining the Immune Checkpoint Landscape in Human Colorectal Cancer Highlights the Relevance of the TIGIT/CD155 Axis for Optimizing Immunotherapy.

Kathleen Ducoin, Linda Bilonda-Mutala, Cécile Deleine

|Apr 30, 2021
The Expression of Anti-Müllerian Hormone Type II Receptor (AMHRII) in Non-Gynecological Solid Tumors Offers Potential for Broad Therapeutic Intervention in Cancer.

Jean-Marc Barret, André Nicolas, Anne Jarry

|Jan 12, 2021
The Caspase-1/IL-18 Axis of the Inflammasome in Tumor Cells: A Modulator of the Th1/Tc1 Response of Tumor-Infiltrating T Lymphocytes in Colorectal Cancer.

Linda Bilonda Mutala, Cécile Deleine, Matilde Karakachoff

Pageof 1

Frequent Collaborators

2 joint publications

Nadine Gervois-Segain

2 joint publications

Nathalie Labarrière

2 joint publications

Emmanuelle Godefroy

1 joint publications

Linda Bilonda Mutala